Document is current
Any future updates will be listed below
-
Authors
White, Joleen T.
Terstappen, Jonne
Levi, Micha
Radivojevic, Andrijana
Noble, Robert
Anderson, Aparna B.
Wise-Blackman, Gwendolyn
Dunne, Michael W.
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-008522)
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 7 November 2024
First Online: 18 December 2024
Declarations
:
: The clinical trial was conducted in accordance with the principles of the Declaration of Helsinki, and Good Clinical Practice guidelines of the International Council for Harmonisation (ICH), and all applicable sections of the United States (US) Code of Federal Regulations (CFR), 21 CFR Parts 50, 56, and 312. The clinical trial protocol was approved by Advarra Institutional Review Board. All participants provided written informed consent.
: Not applicable since no individual patient data shown.
: JTW, ML, RN, ABA, and MWD are employees of Bill & Melinda Gates Medical Research Institute; JT is employed by University Medical Centre Utrecht and received funding to University Medical Centre Utrecht from Bill & Melinda Gates Medical Research Institute; AR is an employee of intiGROWTH LLC and received funding to intiGROWTH LLC from Bill & Melinda Gates Medical Research Institute; GWB is an employee of BioData Solutions and received funding to BioData Solutions from Bill & Melinda Gates Medical Research Institute.
